NCT02791217View on ClinicalTrials.gov

Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2019

Conditions
Lymphoma, B-CellFollicular LymphomaHodgkin LymphomaMultiple Myeloma
Sponsors
All Listed Sponsors
collaborator

Laniado Hospital

OTHER

lead

Assuta Medical Center

OTHER

NCT02791217 - Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool | Biotech Hunter | Biotech Hunter